| __timestamp | BioMarin Pharmaceutical Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 22570000 |
| Thursday, January 1, 2015 | 402271000 | 24378000 |
| Friday, January 1, 2016 | 476593000 | 26621000 |
| Sunday, January 1, 2017 | 554336000 | 28653000 |
| Monday, January 1, 2018 | 604353000 | 37734000 |
| Tuesday, January 1, 2019 | 680924000 | 41884000 |
| Wednesday, January 1, 2020 | 737669000 | 64435000 |
| Friday, January 1, 2021 | 759375000 | 57483000 |
| Saturday, January 1, 2022 | 854009000 | 70062000 |
| Sunday, January 1, 2023 | 937300000 | 52790000 |
| Monday, January 1, 2024 | 1009025000 |
Unleashing insights
In the competitive world of biopharmaceuticals, managing operational costs is crucial for sustained growth. Over the past decade, BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, BioMarin's SG&A costs surged by over 200%, reflecting its aggressive expansion and investment in new therapies. In contrast, Ligand's expenses grew by approximately 130%, indicating a more conservative approach.
This data underscores the diverse strategies employed by these industry leaders, offering valuable insights into their operational priorities and market positioning.
Merck & Co., Inc. and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for Genmab A/S and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Viatris Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Pharming Group N.V.
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Halozyme Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and MannKind Corporation
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends